J Cancer 2023; 14(9):1648-1659. doi:10.7150/jca.83446 This issue Cite

Research Paper

PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer

Lianqin Liu1, Liu Li2, Wufan Zu3, Jiayu Jing4, Guanjun Liu5, Tingyi Sun1,✉, Qi Xie1,✉

1. Department of Pathology, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, the People's Republic of China.
2. Department of Nursing, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, the People's Republic of China.
3. Department of Immunology, School of Basic Medical Science, Xinxiang Medical University, Xinxiang, Henan, 453003, the People's Republic of China.
4. Department of Gynecology, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, the People's Republic of China.
5. Internal Medicine Department of Oncology, Henan Provincial People's Hospital; People's Hospital of Zhengzhou University; People's Hospital of Henan University, Zhengzhou, Henan, 450003, the People's Republic of China.

Citation:
Liu L, Li L, Zu W, Jing J, Liu G, Sun T, Xie Q. PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. J Cancer 2023; 14(9):1648-1659. doi:10.7150/jca.83446. https://www.jcancer.org/v14p1648.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cervical cancer (CC) is one of the leading cancers among the female reproductive system. The piwi-interacting RNA (piRNA) function and biogenesis has been studied in various cancers, including CC. But the precise mechanism of piRNA in CC is still unknown. In our study, we found that piRNA-17458 was overexpressed in CC tissues and cells. piRNA-17458 mimic and inhibitor promoted and suppressed proliferation, migration and invasion ability of CC cells, respectively. We also demonstrated that piRNA-17458 mimic could contribute to tumor growth in mice xenograft models. Besides, we also found that the piRNA-17458 mimic could enhance mRNA N6-methyladenosine(m6A) levels and increase WTAP stability in CC cells, while the effects of the mimic was reversed by the WTAP knockdown. The results of dual luciferase reporter assay showed that WTAP was a direct target of piRNA-17458. Knockdown of WTAP attenuated proliferation, migration and invasion of CC cells in piRNA-17458 mimic group. Our finding not only demonstrates for the first time that piRNA-17458 is overexpressed in CC tissues and cells, but also shows that piRNA-17458 promotes tumorigenesis of CC in a WTAP-mediated m6A methylation manner.

Keywords: piRNA-17458, WTAP, m6A RNA methylation, cervical cancer, malignancy


Citation styles

APA
Liu, L., Li, L., Zu, W., Jing, J., Liu, G., Sun, T., Xie, Q. (2023). PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. Journal of Cancer, 14(9), 1648-1659. https://doi.org/10.7150/jca.83446.

ACS
Liu, L.; Li, L.; Zu, W.; Jing, J.; Liu, G.; Sun, T.; Xie, Q. PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. J. Cancer 2023, 14 (9), 1648-1659. DOI: 10.7150/jca.83446.

NLM
Liu L, Li L, Zu W, Jing J, Liu G, Sun T, Xie Q. PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. J Cancer 2023; 14(9):1648-1659. doi:10.7150/jca.83446. https://www.jcancer.org/v14p1648.htm

CSE
Liu L, Li L, Zu W, Jing J, Liu G, Sun T, Xie Q. 2023. PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. J Cancer. 14(9):1648-1659.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image